Recently, the Food and Drug Administration conditionally approved the sale of RU486, the French abortion pill, in the United States. The drug won't be available widely until mid-next year. Dr. Elizabeth Newhall works in a clinic in Portland, Oregon, where they have been testing the drug with their patients.